A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed)
Tumors or cancer of the NASOPHARYNX.
Tumors or cancer of the NOSE.
Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.
Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.
Facial neoplasms are abnormal growths or tumors that develop in the facial region, which can be benign or malignant, originating from various cell types including epithelial, glandular, connective tissue, and neural crest cells.
The part of the face that is below the eye and to the side of the nose and mouth.
Bleeding from the nose.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
A small space in the skull between the MAXILLA and the SPHENOID BONE, medial to the pterygomaxillary fissure, and connecting to the NASAL CAVITY via the sphenopalatine foramen.
A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.
A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.
Tumors or cancer of the OROPHARYNX.

Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria. (1/70)

Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA). The main symptom is progressive mental retardation. A spectrum of different mutations has been reported in this disease, one missense mutation (Cys163Ser) being responsible for the majority of Finnish cases. We were able to examine 66 Finnish AGU patients for changes in the oral mucosa and 44 of these for changes in facial skin. Biopsy specimens of 16 oral lesions, 12 of them associated with the teeth, plus two facial lesions were studied histologically. Immunohistochemical staining for AGA was performed on 15 oral specimens. Skin was seborrhoeic in adolescent and adult patients, with erythema of the facial skin already common in childhood. Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis. Oedemic buccal mucosa (leucoedema) and gingival overgrowths were more frequent in AGU patients than in controls (p<0.001). Of 16 oral mucosal lesions studied histologically, 15 represented fibroepithelial or epithelial hyperplasias and were reactive in nature. Cytoplasmic vacuolisation was evident in four. Immunohistochemically, expression of AGA in AGU patients' mucosal lesions did not differ from that seen in corresponding lesions of normal subjects. Thus, the high frequency of mucosal overgrowth in AGU patients does not appear to be directly associated with lysosomal storage or with alterations in the level of AGA expression.  (+info)

Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. (2/70)

CONTEXT: Ras gene mutations have been associated to a wide range of human solid tumors. Members of the ras gene family (Ki-ras, Ha-ras and N-ras) are structurally related and code for a protein (p21) known to play an important role in the regulation of normal signal transduction and cell growth. The frequency of ras mutations is different from one type of tumor to another, suggesting that point mutations might be carcinogen-specific. OBJECTIVES: To study the occurrence of Ki-ras and Ha-ras mutations. We also studied the relative level of Ha-ras mRNA in 32 of the head and neck tumors. DESIGN: Case series. SETTING: University referral unit. PARTICIPANTS: 60 head and neck tumors and in 28 Juvenile Nasopharyngeal Angiofibromas (JNA). DIAGNOSTIC TEST: Using PCR-SSCP we examined the occurrence of Ki-ras and Ha-ras mutations. The relative level of Ha-ras mRNA was examined by Northern blot analysis. RESULTS: None of the head and neck tumors or JNA samples showed evidence of mutations within codons 12, 13, 59 and 61 of Ki-ras or Ha-ras genes. However, 17 (53%) of the tumors where gene expression could be examined exhibited increased levels of Ha-ras mRNA compared with the normal tissue derived from the same patient. CONCLUSIONS: Our results demonstrate for the first time that mutations of Ki-ras and Ha-ras genes are not associated with the development of JNA and confirm previous reports indicating that activating ras mutations are absent or rarely involved in head and neck tumors from western world patients. Furthermore, our findings suggest that overexpression of Ha-ras, rather than mutations, might be an important factor in the development and progression of head and neck tumors.  (+info)

Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases. (3/70)

BACKGROUND: Lymphangiomatous polyps are uncommon benign tumors of the tonsils. METHODS: Twenty-six cases of lymphangiomatous polyps diagnosed between 1980 and 1999 were retrieved from the files of the Otorhinolaryngic-Head and Neck Tumor Registry of the Armed Forces Institute of Pathology. Hematoxylin and eosin-stained slides were reviewed to characterize the histologic features of these tumors. Immunohistochemical stains were performed on 15 cases. Clinical follow-up data were obtained. RESULTS: The patients included 13 males and 13 females, ages 3 to 63 years (mean, 25.2 years). Patients experienced dysphagia, sore throat, and the sensation of a mass in the throat. Symptoms were present from a few weeks to years. The tonsillar masses were unilateral in all cases. Clinically, the lesions were frequently mistaken for a neoplasm (n = 18 patients). Grossly, all of the lesions were polypoid and measured 0.5 to 3.8 cm (mean, 1.6 cm). Histologically, the polyps were covered by squamous epithelium showing variable epithelial hyperplasia, dyskeratosis, and lymphocytic epitheliotropism. The masses showed a characteristic submucosal proliferation of small to medium-sized, endothelial-lined, lymph-vascular channels lacking features of malignancy. Collagen, smooth muscle, and adipose tissue were present in the stroma. Intravascular proteinaceous fluid and lymphocytes were noted. Immunohistochemical findings confirmed the endothelial origin of the vascular proliferation and a mixed lymphoid population. The differential diagnosis included fibroepithelial polyp, lymphangioma, juvenile angiofibroma, and squamous papilloma. In all patients with follow-up, complete surgical excision was curative (mean follow-up, 5.4 years; range, 1 mo to 14 years). CONCLUSIONS: We detail the clinical and pathologic features of tonsillar lymphangiomatous polyps. These tumors are uncommon and may clinically be mistaken for a malignant neoplasm. The characteristic histologic features should allow for its correct diagnosis and differentiation from similar appearing tonsillar lesions.  (+info)

Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1. (4/70)

The high frequency of cutaneous manifestations in patients with multiple endocrine neoplasia type 1 (MEN 1) has recently been reported. Since prevalence of some cutaneous diseases varies among different ethnic groups, we examined the frequency of facial angiofibromas in Japanese patients with familial MEN 1. Among 27 patients with germline MEN1 gene mutation and one asymptomatic gene carrier, angiofibromas were identified in 43% (12/28) of the subjects. This frequency was significantly lower than that of Caucasian patients, but nonetheless almost equaled those of pituitary tumors and pancreas endocrine tumors. Angiofibromas should be considered as one of major manifestations in MEN 1 regardless of patients' ethnic origin, and clinicians should pay careful attention to the cutaneous lesions in patients with endocrine tumors.  (+info)

Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. (5/70)

Juvenile nasopharyngeal angiofibromas (JNAs) are locally aggressive vascular tumors occurring predominantly in adolescent males. The pathogenesis of JNAs is unknown. Recently, JNAs have been reported to occur at increased frequency among patients with familial adenomatous polyposis, suggesting that alterations of the adenomatous polyposis coli (APC)/beta-catenin pathway might also be involved in the pathogenesis of sporadic JNAs. We analyzed somatic beta-catenin and APC gene mutations in 16 sporadic JNAs from nonfamilial adenomatous polyposis patients using immunohistochemistry for beta-catenin, and direct DNA sequencing for exon 3 of the beta-catenin gene and the mutation cluster region of the APC gene. Nuclear accumulation of beta-catenin was diffusely present in the stromal cells but not in the endothelial cells of all 16 JNAs. Activating beta-catenin gene mutations were present in 75% (12 of 16) of JNAs. Six JNA patients also had recurrent tumors after surgery, and in all cases the beta-catenin gene status of the recurrent JNA was identical to the initial tumor. No mutations in the mutation cluster region of the APC gene were detected in the four JNAs without beta-catenin mutations. The high frequency of beta-catenin mutations in sporadic JNAs and the presence of identical beta-catenin gene mutations in recurrent tumors indicates that activating beta-catenin gene mutations are important in the pathogenesis of JNAs. The immunohistochemical localization of beta-catenin only to the nuclei of stromal cells further suggests that the stromal cells, rather than endothelial cells, are the neoplastic cells of JNAs.  (+info)

Clinicopathologic analysis of angiomyofibroblastoma of the female genital tract. (6/70)

OBJECTIVE: To study the clinicopathologic features and immunoprofile of angiomyofibroblastoma (AMF) with emphasis on differential diagnosis. METHODS: Seven vulvar, two vaginal and one perineal angiomyofibroblastomas were evaluated by light microscopy and immunohistochemistry. The immunohistochemical studies were performed on paraffin-embedded sections using the standard ABC method with a panel of antibodies. RESULTS: Angiomyofibroblastoma predominantly occurred in middle-aged women in the genital region, especially in the superficial area of the vulva. Clinically, most of the tumors presented as slowly growing painless masses and were often diagnosed as Bartholin's gland cysts. Histologically, the tumors were all well-circumscribed and characterized by alternating hypocellular and hypercellular areas with abundant thin-walled blood vessels. The tumor cells were bland and spindle-shaped or epithelioid and tended to concentrate around the vessels or cluster in small nests. Immunohistochemically, the tumor cells expressed vimentin and estrogen receptor protein in all 10 cases and desmin in 9 cases. Three cases showed weak or focal immunoreactivity to alpha-smooth muscle actin and muscle specific actin. All ten patients were treated by local excision. Follow-up showed a benign course with no signs of recurrence. CONCLUSIONS: Angiomyofibroblastoma is a distinctive neoplasm that has a propensity to occur in the female genital tract. Recognition of this entity is important to avoid misdiagnosis with other vulvar angiomyxoid neoplasms.  (+info)

Risks of tumor embolization in the presence of an unrecognized patent foramen ovale: case report. (7/70)

A patent foramen ovale (PFO) is a fairly common septal defect in the general population. Paradoxical embolization through a PFO is a known cause of stroke. Preprocedural recognition of a PFO in a patient undergoing particulate arterial embolization can help reduce the risk of cerebral infarction.  (+info)

Recurrent angiofibroma invading the skull base--case report. (8/70)

A 16-year-old male presented with a massive nasopharyngeal angiofibroma arising in the nasopharynx, nasal cavity, pterygopalatine fossa, and infratemporal fossa, and eroding the pterygoid process of the sphenoid bone. Neuroimaging showed the tumor had infiltrated the parasellar region from the middle cranial fossa and reached the cavernous sinus. The tumor was almost completely removed macroscopically by a modified transbasal approach.  (+info)

Angiofibroma is a benign tumor that most commonly occurs in the nasopharynx (the upper part of the throat behind the nose) in adolescents and young adults, particularly males. It is composed of blood vessels and fibrous tissue. Angiofibromas are also known as juvenile nasopharyngeal angiofibromas because they often occur in young people and originate in the nasopharynx.

These tumors can cause symptoms such as nosebleeds, nasal congestion, and difficulty breathing through the nose. In some cases, they may also cause hearing problems or double vision. Angiofibromas are typically treated with surgery to remove the tumor. Radiation therapy may also be used in some cases.

It is important to note that angiofibroma is a specific type of tumor that has distinct characteristics and is treated differently from other types of tumors. If you have any concerns about this condition or if you are experiencing symptoms that you think may be related to an angiofibroma, it is important to consult with a healthcare professional for proper diagnosis and treatment.

Nasopharyngeal neoplasms refer to abnormal growths or tumors in the nasopharynx, which is the upper part of the pharynx (throat) behind the nose. These growths can be benign (non-cancerous) or malignant (cancerous).

Malignant nasopharyngeal neoplasms are often referred to as nasopharyngeal carcinoma or cancer. There are different types of nasopharyngeal carcinomas, including keratinizing squamous cell carcinoma, non-keratinizing carcinoma, and basaloid squamous cell carcinoma.

The risk factors for developing nasopharyngeal neoplasms include exposure to the Epstein-Barr virus (EBV), consumption of certain foods, smoking, and genetic factors. Symptoms may include a lump in the neck, nosebleeds, hearing loss, ringing in the ears, and difficulty swallowing or speaking. Treatment options depend on the type, size, and stage of the neoplasm and may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

Nose neoplasms refer to abnormal growths or tumors in the nasal cavity or paranasal sinuses. These growths can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow-growing and do not spread to other parts of the body, while malignant neoplasms can invade surrounding tissues and have the potential to metastasize.

Nose neoplasms can cause various symptoms such as nasal congestion, nosebleeds, difficulty breathing through the nose, loss of smell, facial pain or numbness, and visual changes if they affect the eye. The diagnosis of nose neoplasms usually involves a combination of physical examination, imaging studies (such as CT or MRI scans), and biopsy to determine the type and extent of the growth. Treatment options depend on the type, size, location, and stage of the neoplasm and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Neoplasms in muscle tissue refer to abnormal and excessive growths of muscle cells that can be benign or malignant. These growths can arise from any of the three types of muscle tissue: skeletal, cardiac, or smooth muscle. Neoplasms in muscle tissue are classified based on their origin, behavior, and histological features.

Benign neoplasms in muscle tissue include leiomyomas (smooth muscle), rhabdomyomas (skeletal muscle), and myxomas (cardiac muscle). These tumors are usually slow-growing and do not invade surrounding tissues or spread to other parts of the body.

Malignant neoplasms in muscle tissue, also known as sarcomas, include leiomyosarcoma (smooth muscle), rhabdomyosarcoma (skeletal muscle), and angiosarcoma (cardiac muscle). These tumors are aggressive, invasive, and have the potential to metastasize to other parts of the body.

Symptoms of neoplasms in muscle tissue depend on their location, size, and type. They may include a painless or painful mass, weakness, fatigue, weight loss, and difficulty swallowing or breathing. Treatment options for neoplasms in muscle tissue include surgery, radiation therapy, chemotherapy, and targeted therapy. The choice of treatment depends on the type, stage, location, and patient's overall health condition.

Nasal obstruction is a medical condition that refers to any blockage or restriction in the normal flow of air through the nasal passages. This can be caused by various factors such as inflammation, swelling, or physical abnormalities in the nasal cavity. Common causes of nasal obstruction include allergies, sinusitis, deviated septum, enlarged turbinates, and nasal polyps. Symptoms may include difficulty breathing through the nose, nasal congestion, and nasal discharge. Treatment options depend on the underlying cause and may include medications, surgery, or lifestyle changes.

Facial neoplasms refer to abnormal growths or tumors that develop in the tissues of the face. These growths can be benign (non-cancerous) or malignant (cancerous). Facial neoplasms can occur in any of the facial structures, including the skin, muscles, bones, nerves, and glands.

Benign facial neoplasms are typically slow-growing and do not spread to other parts of the body. Examples include papillomas, hemangiomas, and neurofibromas. While these tumors are usually harmless, they can cause cosmetic concerns or interfere with normal facial function.

Malignant facial neoplasms, on the other hand, can be aggressive and invasive. They can spread to other parts of the face, as well as to distant sites in the body. Common types of malignant facial neoplasms include basal cell carcinoma, squamous cell carcinoma, and melanoma.

Treatment for facial neoplasms depends on several factors, including the type, size, location, and stage of the tumor. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. It is important to seek medical attention promptly if you notice any unusual growths or changes in the skin or tissues of your face.

A "cheek" is the fleshy, muscular area of the face that forms the side of the face below the eye and above the jaw. It contains the buccinator muscle, which helps with chewing by moving food to the back teeth for grinding and also assists in speaking and forming facial expressions. The cheek also contains several sensory receptors that allow us to perceive touch, temperature, and pain in this area of the face. Additionally, there is a mucous membrane lining inside the mouth cavity called the buccal mucosa which covers the inner surface of the cheek.

Epistaxis is the medical term for nosebleed. It refers to the bleeding from the nostrils or nasal cavity, which can be caused by various factors such as dryness, trauma, inflammation, high blood pressure, or use of blood-thinning medications. Nosebleeds can range from minor nuisances to potentially life-threatening emergencies, depending on the severity and underlying cause. If you are experiencing a nosebleed that does not stop after 20 minutes of applying direct pressure, or if you are coughing up or vomiting blood, seek medical attention immediately.

Endoscopy is a medical procedure that involves the use of an endoscope, which is a flexible tube with a light and camera at the end, to examine the interior of a body cavity or organ. The endoscope is inserted through a natural opening in the body, such as the mouth or anus, or through a small incision. The images captured by the camera are transmitted to a monitor, allowing the physician to visualize the internal structures and detect any abnormalities, such as inflammation, ulcers, or tumors. Endoscopy can also be used for diagnostic purposes, such as taking tissue samples for biopsy, or for therapeutic purposes, such as removing polyps or performing minimally invasive surgeries.

The pterygopalatine fossa is a small, irregularly shaped space located in the skull, lateral to the nasal cavity and inferior to the orbit. It serves as a critical communications center for several important nerves, arteries, and veins that provide sensory innervation, vasomotor control, and blood supply to various structures in the head and neck region.

The following are some key components of the pterygopalatine fossa:

1. Nerves: The pterygopalatine ganglion is a major component of this fossa, which contains postganglionic parasympathetic fibers, sympathetic fibers, and sensory fibers from various nerves, including the maxillary nerve (V2), greater petrosal nerve, deep petrosal nerve, and nerve of the pterygoid canal.

2. Arteries: The maxillary artery, a branch of the external carotid artery, enters the fossa through the foramen rotundum and divides into several branches that supply various structures in the head and neck region, such as the sphenopalatine artery, posterior superior alveolar artery, infraorbital artery, and greater palatine artery.

3. Veins: The pterygoid venous plexus is a complex network of veins located in and around the fossa that communicates with various venous systems, including the facial vein, cavernous sinus, and inferior ophthalmic vein.

The pterygopalatine fossa plays an essential role in several physiological functions, such as lacrimation, salivation, and vasodilation of blood vessels in the nasal cavity and paranasal sinuses. Additionally, it is a potential site for the spread of infection or neoplasm from the oral cavity, nasal cavity, or paranasal sinuses to other regions of the head and neck.

A lipoma is a common, benign (non-cancerous) soft tissue growth. It is composed of adipose or fatty tissue and typically found just beneath the skin, but they can also occur deeper within the body. Lipomas are usually round, moveable, and painless, although they may cause discomfort if they grow large enough to put pressure on nearby nerves or if they're located in a sensitive area. They generally grow slowly over time. Surgical removal is an option if the lipoma becomes bothersome or grows significantly in size. It's important to note that while lipomas are typically harmless, any new lumps or bumps should be evaluated by a healthcare professional to confirm the diagnosis and rule out other more serious conditions.

Therapeutic embolization is a medical procedure that involves intentionally blocking or obstructing blood vessels to stop excessive bleeding or block the flow of blood to a tumor or abnormal tissue. This is typically accomplished by injecting small particles, such as microspheres or coils, into the targeted blood vessel through a catheter, which is inserted into a larger blood vessel and guided to the desired location using imaging techniques like X-ray or CT scanning. The goal of therapeutic embolization is to reduce the size of a tumor, control bleeding, or block off abnormal blood vessels that are causing problems.

Oropharyngeal neoplasms refer to abnormal growths or tumors in the oropharynx, which is the middle part of the pharynx (throat) that includes the back one-third of the tongue, the soft palate, the side and back walls of the throat, and the tonsils. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Oropharyngeal cancer is a significant global health concern, with squamous cell carcinoma being the most common type of malignant neoplasm in this region. The primary risk factors for oropharyngeal cancers include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Early detection and treatment are crucial for improving outcomes and survival rates.

Angiofibroma of soft tissue is also named angiofibroma, not otherwise specified, by the World Health Organization, 2020. The ... "Picture of Angiofibroma (Facial) on MedicineNet". Macri, A.; Kwan, E.; Tanner, L. S. (2021). "Cutaneous Angiofibroma". ... Angiofibroma (AGF) is a descriptive term for a wide range of benign skin or mucous membrane (i.e. the outer membrane lining ... Cellular angiofibroma is usually a small, slow-growing tumor arising in the vulva-vaginal areas of adult woman and the inguinal ...
Juvenile angiofibroma is a noncancerous growth that causes bleeding in the nose and sinuses. It is most often seen in boys and ... Juvenile angiofibroma is a noncancerous growth that causes bleeding in the nose and sinuses. It is most often seen in boys and ... Juvenile angiofibroma is a noncancerous growth that causes bleeding in the nose and sinuses. It is most often seen in boys and ... Juvenile angiofibroma is not very common. It is most often found in adolescent boys. The tumor contains many blood vessels and ...
Juvenile angiofibroma (JNA) is a benign tumor that tends to bleed and occurs in the nasopharynx of prepubertal and adolescent ... Juvenile nasopharyngeal angiofibroma (JNA) occurs exclusively in males. Females with juvenile nasopharyngeal angiofibroma (JNA ... encoded search term (Juvenile Nasopharyngeal Angiofibroma) and Juvenile Nasopharyngeal Angiofibroma What to Read Next on ... Juvenile Nasopharyngeal Angiofibroma. Updated: Feb 10, 2021 * Author: Ted L Tewfik, MD; Chief Editor: Arlen D Meyers, MD, MBA ...
About Facial Angiofibroma Associated with Tuberous Sclerosis Complex Tuberous sclerosis complex (TSC) is an autosomal dominant ... HYFTOR is the first and only clear topical medication approved by the FDA to treat facial angiofibroma associated with tuberous ... HYFTOR is the first and only topical medication approved by the FDA to treat facial angiofibroma associated with tuberous ... HYFTOR™ (sirolimus topical gel) 0.2% is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis ...
Cellular angiofibroma is a rare benign mesenchymal tumour of middle-aged adults. This tumour is usually located in the ... This is believed to be the first reported case of sarcomatous transformation in a cellular angiofibroma. ...
By submitting your email address, you are opting in and may be provided with online advertisements or communications on Nobelpharma or third-party websites that are tailored to you, for example, on the basis of nonidentifying information or of your web browsing activity. When a Nobelpharma communication is delivered to you, you will see information about how to opt-out. By clicking the arrow, you agree and understand that your information will be governed by our Privacy Policy.. ...
Home head and neck radiology Juvenile angiofibroma radiopath series Angiofibroma-Radiopath Series ... Angiofibroma-Radiopath Series Reviewed by Sumer Sethi on Monday, April 13, 2015 Rating: 5 ... Monday, April 13, 2015 head and neck radiology, Juvenile angiofibroma, radiopath series ... We present a case of angiofibroma with Radio-path correlation for integrated learning approach.. ...
Keywords: angiofibroma, juvenile nasopharyngeal angiofibroma, nasopharyngeal tumour. Singapore Med J 2009; 50(3): 261-264. ... is a retrospective study that aimed to examine the outcomes of patients presenting with juvenile nasopharyngeal angiofibroma ( ...
Treatment outcomes of juvenile nasopharyngeal angiofibroma according to surgical approach. Dong Woo Hyun, Ji Hwan Ryu, Yoo Suk ... Treatment outcomes of juvenile nasopharyngeal angiofibroma according to surgical approach. / Hyun, Dong Woo; Ryu, Ji Hwan; Kim ... Treatment outcomes of juvenile nasopharyngeal angiofibroma according to surgical approach. In: International Journal of ... Treatment outcomes of juvenile nasopharyngeal angiofibroma according to surgical approach. International Journal of Pediatric ...
You are at:Home»Embj»JUVENILE NASOPHARYNGEAL ANGIOFIBROMA: AN ENDOSCOPIC APPROACH WITH PRE-OPERATIVE EMBOLIZATION SUPPORTED BY ... JUVENILE NASOPHARYNGEAL ANGIOFIBROMA: AN ENDOSCOPIC APPROACH WITH PRE-OPERATIVE EMBOLIZATION SUPPORTED BY NEURONAVIGATED ... combined to the preoperative embolization and the follow-up management of a patient with a Juvenile Nasopharyngeal Angiofibroma ...
Extra Nasopharyngeal Angiofibroma (ENPA) is very rare benign but locally destructive vascular tumor. We present a rare case of ... A Rare Case of Extra Nasopharyngeal Angiofibroma of the Ethmoid Sinus with Orbital Extension. Althbety M*, Alkarzae M, ... Extra Nasopharyngeal Angiofibroma (ENPA) is very rare benign but locally destructive vascular tumor. We present a rare case of ... Citation: Althbety M, Alkarzae M, Almubarak Z, Elbana A, Al-bulal L (2017) A Rare Case of Extra Nasopharyngeal Angiofibroma of ...
To assess and analyze the clinical presentation of Juvenile nasopharyngeal angiofibroma and analyze the complications ... To assess and analyze the clinical presentation of Juvenile nasopharyngeal angiofibroma and analyze the complications ... "Lefort 1 Access for Juvenile Nasopharyngeal Angiofibroma Treated Without Angiographic Embolization.," Pakistan Journal of ...
Juvenile nasal angiofibroma by Dr. Muhammad Bin Zulfiqar. Juvenile nasal angiofibroma. Dr. Muhammad Bin Zulfiqar•4.4K. views ...
Juvenile Nasopharyngeal Angiofibroma (JNA) JNA is the most common vascular mass found in the nasal cavity. It is typically seen ... Alshaikh NA, Eleftheriadou A. Juvenile nasopharyngeal angiofibroma staging: An overview. Ear Nose Throat J. 2015 Jun;94(6):E12- ... Bakshi SS, Bhattacharjee S. Juvenile Nasopharyngeal Angiofibroma. J Pediatr Hematol Oncol. 2016 Aug;38(6):491-2. [PubMed: ...
Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian ...
Juvenile nasopharyngeal angiofibroma: interobserver agreement in cancer staging using computed tomography Artigos. Gusso, ... interobserver agreement on the analysis of computed tomography scans of 15 patients with juvenile nasopharyngeal angiofibroma, ...
Juvenile Nasopharyngeal Angiofibroma A juvenile nasopharyngeal angiofibroma is a growth in the area behind the nose. Theyre ... Juvenile Nasopharyngeal Angiofibroma A juvenile nasopharyngeal angiofibroma is a growth in the area behind the nose. Theyre ...
juvenile nasopharyngeal angiofibroma. *stop the flow of blood through an abnormal connection between arteries and veins ( ...
General features; specifically: nasal polyps, nasopharyngeal angiofibroma, sinonasal inverted papilloma. Classification of naso ...
How can doctors tell if my child has a juvenile angiofibroma? Doctors will usually do a CT scan or an MRI. ...
Juvenile Nasopharyngeal Angiofibroma and Familial Adenomatous Polyposis. Ear Nose Throat J. 2020 Jun 16:145561320934602. doi: ...
Nasopharyngeal angiofibroma. * Neuroendocrine adenoma of the middle ear, middle ear adenoma, carcinoid tumor of the middle ear ...
Juvenile Nasopharyngeal Angiofibroma. *Vestibular Schwannoma (Acoustic Neuroma). *Meningioma. *Fibrous Dysplasia. *Chordoma. * ...
Be sure to have your doctor check any bumps in your mouth to make sure that is not ...
Yazici B, Setzen G, Meyer DR, et al. Giant cell angiofibroma of the nasolacrimal duct. Ophthal Plast Reconstr Surg 2001;17:202- ...
Almost all juvenile angiofibroma patients are males. There are more cases in Egypt, India, Southeast Asia, Kenya, and Mexico ... We use imaging scans to help us understand the size and extent of the angiofibroma tumors. Computed tomography (CT scans) show ... Juvenile angiofibroma symptoms relate to the size and direction of extension in the growth. ...
Read more about Locally Advanced Staged Juvenile Nasopharyngeal Angiofibroma Treated with Endoscopic Endonasal Approach and ... Locally Advanced Staged Juvenile Nasopharyngeal Angiofibroma Treated with Endoscopic Endonasal Approach and Angio-embolization ...
Tags: Angiofibroma, Ataxia, Bells Palsy, Bells Palsy, Calcium, Calcium Carbonate, Cancer, Cartilage, Central Nervous System, ... Juvenile angiofibroma is an invasive non-cancerous growth in the back of the nose or nasopharynx usually found in adolescent ... In the small study "Flutamide as a Preoperative Treatment in Juveile Angiofibroma (JA) with Intracranial Invasion. Report of 7 ... would be helpful in reducing juvenile angiofibroma. No advantages were found in using Flutamide, but more research should be ...
Current management of juvenile nasopharyngeal angiofibroma: a tertiary center experience 1999-2007. Am J Rhinol Allergy 23 (3 ...

No FAQ available that match "angiofibroma"

No images available that match "angiofibroma"